Aristo Pharma Gmbh opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Aristo Pharma Gmbh

Patent Number:
Title:
Methods And Compositions For Treating Cancer
Opposition Date:
Jan 11, 2022
Patent Number:
Title:
Rapid Dissolution Formulation Of A Calcium Receptor-Active Compound
Applicant:
Opposition Date:
Apr 14, 2021
Patent Number:
Title:
Dosage Form Containing Oxycodone And Naloxone
Opposition Date:
Jan 9, 2020

Competitors of Aristo Pharma Gmbh

AMGEN INC.

AMGEN, INC

COUGAR BIOTECHNOLOGY, INC.

Want to track Aristo Pharma Gmbh?

Feel free to send us a message here and we will get back to you